Cyclin H antibody (Thr315)
Quick Overview for Cyclin H antibody (Thr315) (ABIN2138639)
Target
See all Cyclin H (CCNH) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- Thr315
- 
                                            Immunogen
- Cyclin H antibody was raised in Rabbit using a synthetic non-phosphopeptide derived from human Cyclin H around the phosphorylation site of Thr315 (E-W-TP-D-D) as the immunogen
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- WB: 1:500-1:1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:20000
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Concentration
- Lot specific
- 
                                            Buffer
- PBS buffer (without Mg2+and Ca2+), pH 7.4, 150 mM NaCl with 0.02 % sodium azide and 50 % glycerol
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handling Advice
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
- 
                                            Storage
- 4 °C/-20 °C
- 
                                            Storage Comment
- Store at -20 °C for 1 year, store at 2-8 °C for up to 1 month
 
- 
                                            
- 
    - Cyclin H (CCNH)
- 
                                            Alternative Name
- Cyclin H
- 
                                            Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases, M Phase
 Target
- 
                    
 
                                     
                                     
                                    